MB-108

N/A

Report date: 2023/12/20 18:00:44

Base Information

Drug NameMB-108
Drug Alias Namechimeric oHSVChimeric Oncolytic Herpes Simplex Virus(University Of Alabama At Birmingham)C-134MB-108IRS-1 HSV-C-134
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGliosarcomaGlioblastomaAstrocytoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesMustang Bio IncUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsGliosarcomaGlioblastomaAstrocytoma
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A